Clinical, Pathologic, and Treatment Characteristics
| Characteristic | n = 20 |
|---|---|
| Age (y) | |
| Median | 50 |
| Range | 19–86 |
| Sex | |
| Male | 10 (50%) |
| Female | 10 (50%) |
| Site | |
| Extremity | 16 (80%) |
| Retroperitoneum/abdomen | 1 (5%) |
| Chest/trunk | 3 (15%) |
| Neoadjuvant therapy | |
| Chemotherapy | 6 (30%) |
| Chemo-/radiotherapy | 14 (70%) |
| Pathologic necrosis | |
| ≥95% (responder) | 6 (30%) |
| <95% (nonresponder) | 14 (70%) |